new orleans pharmaceutical company behind widely advertised blood thinner xarelto reached million settlement lawsuit alleging patient adequately warned risk life threatening complication plaintiff attorney manufacturer said monday bayer healthcare janssen pharmaceutical six case went trial bayer said emailed statement settlement allows company avoid distraction significant cost continued litigation xarelto brand name drug rivaroxaban among us treatment prevention blood clot leg lung prevention stroke people irregular heartbeat heavily advertised television hawked widely seen ad featuring comedian kevin nealon golfer arnold palmer nascar driver brian vickers lawsuit dating back consolidated federal court new orleans involved claim user medication marketed bayer healthcare janssen pharmaceutical adequately informed risk life threatening complication including internal bleeding stroke death admission liability remain steadfast claim raised litigation contradict year scientific data u food drug administration repeated confirmation xarelto safety efficacy sarah freeman spokeswoman janssen pharmaceutical said emailed statement attorney plaintiff called settlement fair resolution statement outlining detail said court appointed special master claim administrator appointed manage claim process appeal may taken four year six separate trial litigation like important way consumer voice matter drug safety lead plaintiff attorney brian barr said release u district judge eldon faldon presided case issued series order monday regarding implementation settlement detailed settlement document filed monday midday plaintiff statement said addition addressing lawsuit already part multidistrict litigation agreement resolve newly filed claim retained lawyer investigate xarelto related personal injury claim march register claim march file suit april neither side estimate much individual might get payment substantially reduced people filed dec first suffered injury attribute drug march statement plaintiff lawyer said 